SEC Form 4 · accession 0001144204-17-010429
Neurotrope, Inc. · NTRP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew D Perlman
Director
Period of report
Feb 17, 2017
Accepted (ET)
Feb 22, 2017 · 5:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001513856
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $15.77 | Feb 17, 2017 | A | 9,375 | A | — | Feb 17, 2027 | Common Stock | 9,375 | 9,375 | D |
Explanation of responses
- F1These securities were issued in connection with the Reporting Person's appointment as a non-employee director to the Issuer's board of directors and his service on the committees thereof.
- F2The stock options shall vest in equal daily installments over a five-year period beginning on the date of grant.